• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
338.0498657
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
41.3
39096.73
EPS(TTM)
Face Value()
Div & Yield %
75.78
2
0.9
 

ebravea beverages ltd
Guru Krupa Gems & Jewellery standalone net profit declines 70.00% in the March 2026 quarter
May 30,2026
Net profit of Guru Krupa Gems & Jewellery declined 70.00% to Rs 0.09 crore in the quarter ended March 2026 as against Rs 0.30 crore during the previous quarter ended March 2025. Sales declined 84.66% to Rs 6.16 crore in the quarter ended March 2026 as against Rs 40.15 crore during the previous quarter ended March 2025.

For the full year,net profit declined 16.18% to Rs 0.57 crore in the year ended March 2026 as against Rs 0.68 crore during the previous year ended March 2025. Sales declined 73.81% to Rs 29.59 crore in the year ended March 2026 as against Rs 112.98 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales6.1640.15 -85 29.59112.98 -74
OPM %2.111.00 -2.770.96 -
PBDT0.220.44 -50 0.850.98 -13
PBT0.150.43 -65 0.780.91 -14
NP0.090.30 -70 0.570.68 -16